Related Experiment Video
Updated: Jun 23, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.0K
Bio-inspired deep learning-personalized ensemble Alzheimer's diagnosis model for mental well-being
Ajmeera Kiran1, Mahmood Alsaadi2, Ashit Kumar Dutta3
1Dept. of Computer Science and Engineering, MLR Institute of Technology, Dundigal, Hyderabad, Telangana, 500043, India.
SLAS Technology
|June 20, 2024
Summary
This study introduces a personalized dynamic ensemble convolution neural network (PDECNN) for Alzheimer's Diagnosis (AD). The model enhances accuracy by focusing on individual sample differences and identifying specific brain regions affected by Alzheimer's disease.
Area of Science:
- Neuroscience
- Artificial Intelligence
- Medical Imaging Analysis
Background:
- Current Alzheimer's Diagnosis (AD) models often overlook individual patient differences, impacting diagnostic accuracy.
- A need exists for personalized classification strategies that account for sample-specific variations in disease progression.
Purpose of the Study:
- To introduce a novel personalized dynamic ensemble convolution neural network (PDECNN) for improved Alzheimer's Diagnosis (AD).
- To develop a model capable of dynamically adjusting to sample-specific brain degeneration patterns.
Main Methods:
- Proposed a personalized dynamic ensemble convolution neural network (PDECNN) model.
- Employed an attention mechanism to evaluate degeneration in specific brain regions.
- Dynamically selected and integrated brain region features based on degeneration levels.
Main Results:
- The PDECNN model demonstrated improved classification accuracy by 4%, 11%, and 8% across different metrics.
- Identified degraded brain regions showed high consistency with known clinical manifestations of Alzheimer's disease.
- The model successfully adapted to variations in brain area degeneration across different samples.
Conclusions:
- The PDECNN model offers a personalized approach to Alzheimer's Diagnosis (AD) by accounting for individual sample distinctiveness.
- This method enhances diagnostic importance by identifying sample-specific degraded brain areas.
- The PDECNN model represents a significant advancement in AI-driven diagnostic tools for neurodegenerative diseases.
Related Concept Videos
Alzheimer's Disease: Overview
462
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
462
Alzheimer's Disease: Treatment
179
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
179
Dementia
110
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
110

